ABVOCUS

Serial Number 97518236
606

Registration Progress

Application Filed
Jul 25, 2022
Under Examination
Feb 20, 2024
Approved for Publication
Dec 26, 2023
Published for Opposition
Dec 26, 2023
Registered

Attorney Assistance

Abandonment Notice E-Mailed - No Use Statement Filed
Due: Nov 22, 2025 18 days
Revival assistance for abandoned trademark

Trademark Image

ABVOCUS

Basic Information

Serial Number
97518236
Filing Date
July 25, 2022
Published for Opposition
December 26, 2023
Abandonment Date
September 22, 2025
Drawing Code
4

Status Summary

Current Status
Inactive
Status Code
606
Status Date
Sep 22, 2025
Classes
005 042

Rights Holder

AADi Bioscience, Inc.

03
Address
17383 Sunset Blvd., Suite A250
Pacific Palisades, CA 90272

Ownership History

AADi Bioscience, Inc.

Original Applicant
03
Pacific Palisades, CA

AADi Bioscience, Inc.

Owner at Publication
03
Pacific Palisades, CA

Legal Representation

Attorney
Chelsea E. Carbone

USPTO Deadlines

Next Deadline
18 days remaining
Abandonment Notice E-Mailed - No Use Statement Filed
Due Date
November 22, 2025

Application History

31 events
Date Code Type Description Documents
Sep 22, 2025 MAB6 E ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED Loading...
Sep 22, 2025 ABN6 S ABANDONMENT - NO USE STATEMENT FILED Loading...
Jul 15, 2025 DOCK D ASSIGNED TO EXAMINER Loading...
Feb 4, 2025 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Feb 4, 2025 EX2G S SOU EXTENSION 2 GRANTED Loading...
Feb 3, 2025 EXT2 S SOU EXTENSION 2 FILED Loading...
Feb 3, 2025 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Aug 2, 2024 EXT1 S SOU EXTENSION 1 FILED Loading...
Aug 2, 2024 EX1G S SOU EXTENSION 1 GRANTED Loading...
Aug 2, 2024 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Aug 2, 2024 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Feb 20, 2024 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
Jan 8, 2024 COAR I TEAS CHANGE OF OWNER ADDRESS RECEIVED Loading...
Jan 8, 2024 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED Loading...
Jan 8, 2024 CHAN I APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED Loading...
Dec 26, 2023 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Dec 26, 2023 PUBO A PUBLISHED FOR OPPOSITION Loading...
Dec 6, 2023 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Nov 21, 2023 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Nov 21, 2023 XAEC I EXAMINER'S AMENDMENT ENTERED Loading...
Nov 21, 2023 GNEN O NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED Loading...
Nov 21, 2023 GNEA O EXAMINERS AMENDMENT E-MAILED Loading...
Nov 21, 2023 CNEA R EXAMINERS AMENDMENT -WRITTEN Loading...
Aug 25, 2023 XELG O APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED Loading...
Aug 25, 2023 XELR I APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED Loading...
May 26, 2023 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
May 26, 2023 GNRT F NON-FINAL ACTION E-MAILED Loading...
May 26, 2023 CNRT R NON-FINAL ACTION WRITTEN Loading...
May 10, 2023 DOCK D ASSIGNED TO EXAMINER Loading...
Aug 16, 2022 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Jul 28, 2022 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 005
Pharmaceutical preparations for the treatment and prevention of cancer, cardiovascular disease, epilepsy and mitochondrial disease; vaccine preparations; pharmaceutical preparations, namely, a drug formulation comprising nanoparticles of sirolimus and albumin for use in the treatment of diseases and disorders in the fields of angiology, cardiology, endocrinology, gastroenterology, geriatrics, hematology, hepatology, nephrology, neurology, oncology, pulmonology, pneumology, respirology, rheumatology, anesthesiology, urology, dermatology, gynecology, ophthalmology, infectiology, and psychiatry; pharmaceutical preparations, namely, a drug formulation comprising nanoparticles of sirolimus and albumin for use in pediatric, geriatric, emergency, family, and human preventative medicine for the treatment of cancer, cardiovascular disease, epilepsy and mitochondrial disease; pharmaceutical preparations for the treatment of cancer, cardiovascular disease, epilepsy and mitochondrial disease
Class 042
Medical and pharmaceutical research services; pharmaceutical research and development; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; medical and scientific research, namely, conducting clinical trials for others; laboratory research services relating to pharmaceuticals; scientific and technological services, namely, scientific research services in the field of process development, validation, qualification, and manufacturing of pharmaceuticals and biopharmaceuticals; scientific research and technological services consultation services in the field of development, manufacturing and testing of pharmaceuticals and biopharmaceuticals; providing product research and development in the pharmaceutical field for purposes of drug discovery process development, drug discovery validation, drug discovery qualification, and drug discovery manufacturing of pharmaceuticals and biopharmaceuticals; scientific research and technological consultation services in the field of pharmaceutical research and pharmacology; custom development of pharmaceutical, biopharmaceutical and chemical products; providing evaluation and testing for pharmaceutical, biopharmaceutical and chemical products, and medical devices featuring testing for safety, toxicity, content, identity, purity, configuration and function for others, using chemical, in vitro or in vivo assays, analyses and models; pre-clinical and non-clinical evaluation and testing of pharmaceutical, biopharmaceutical and chemical products performed primarily using animals and other biological models; pharmaceutical, biopharmaceutical, and chemical research and development for others; pharmaceutical research in the fields of angiology, cardiology, endocrinology, gastroenterology, geriatrics, hematology, hepatology, nephrology, neurology, oncology, pulmonology, pneumology, respirology, rheumatology, anesthesiology, urology, dermatology, gynecology, ophthalmology, infectiology, and psychiatry; pharmaceutical research for use in pediatric, geriatric, emergency, family, and preventative medicine; pharmaceutical research for the treatment of infectious, deficiency, hereditary, and physiological diseases

Classification

International Classes
005 042